Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: Effect of dose on lesion detection and delineation
Open Access
- 31 October 2001
- journal article
- clinical trial
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 14 (5) , 525-539
- https://doi.org/10.1002/jmri.1216
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Gadobenate Dimeglumine 0.5 M Solution for Injection (MultiHance®): Pharmaceutical Formulation and Physicochemical Properties of a New Magnetic Resonance Imaging Contrast MediumJournal of Computer Assisted Tomography, 1999
- NMRD Assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a Nonionic MRI AgentInvestigative Radiology, 1999
- Brain metastasesCurrent Problems in Cancer, 1999
- Diagnostic Accuracy of MRI Compared to CCT in Patients with Brain MetastasesJournal of Neuro-Oncology, 1999
- Brain Metastases — Comparison of Gadodiamide Injection-Enhanced MR Imaging at Standard and High Dose, Contrast-Enhanced CT and Non-Contrast-Enhanced MR ImagingActa Radiologica, 1995
- Safety and Efficacy of Dotarem (Gd-DOTA) versus Magnevist (Gd-DTPA) in Magnetic Resonance Imaging of the Central Nervous SystemInvestigative Radiology, 1995
- Pharmacokinetics, Dose Proportionality, and Tolerability of Gadobutrol after Single Intravenous Injection in Healthy VolunteersInvestigative Radiology, 1994
- Brain MetastasesNeurologic Clinics, 1991
- Gadolinium-DOTA Enhanced MR Imaging of Intracranial LesionsJournal of Computer Assisted Tomography, 1989
- Increased detection of intracranial metastases with intravenous Gd-DTPA.Radiology, 1987